Search results
Is Krystal Biotech, Inc. (NASDAQ:KRYS) the Premier Gene Therapy Stock for Your Portfolio?
Insider Monkey via Yahoo Finance· 15 hours agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
House Oversight top Democrat Raskin promotes discredited Trump bleach claim at Fauci hearing
Just the News· 20 hours agoDemocratic Rep. Jamie Raskin on Monday repeated a false claim during a House Oversight Committee...
10 AI applications for companies that want to streamline their business and improve customer...
Business Insider via Yahoo News· 5 days agoAs BI's "CXO AI Playbook" series has unfolded, we've noticed certain technology initiatives are...
Avirmax Biopharma Inc. Receives IND Approval for Phase I/IIa Trial to Treat Wet AMD including PCV
The Yuma Sun· 5 days agoI/IIa clinical trial for its gene therapy treatment targeting wet Age-related Macular Degeneration (AMD) including Polypoidal Choroidal Vasculopathy (PCV). This significant milestone enables ...
NIIMBL collaborates on review of vaccine process technology developments
WKBN 27 Youngstown· 7 days agoThe National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has published "Vaccine process technology—a decade of progress" in Biotechnology and Bioengineering ...
Mexico’s first female president has Bay Area connection
KRON via Yahoo News· 18 hours ago(KRON) — Mexico made history this weekend in electing the first woman president in the nation’s more...
Moderna’s vaccine for RSV gets FDA approval for people 60 and older - The Boston Globe
The Boston Globe· 4 days agoModerna said Friday that US drug regulators have approved its second product, a vaccine for...
Lake Erie Transit general manager celebrates retirement
The Monroe News via Yahoo News· 1 day ago“Everything that we do internally, technology-wise, has made us safer, and we communicate better.”...
Momentum Builds for Amplification-Free Molecular Diagnostics, But Significant Hurdles Remain
GenomeWeb News· 4 days agoNucleic acid amplification technologies (NAATs) are both the bedrock and biggest bottleneck of molecular diagnostics, enabling sensitive and specific infectious disease assays that also tend ...
Theralase(R) Release's 1Q2024 Financial Statements
StreetInsider· 5 days agoTORONTO, ON / ACCESSWIRE / May 30, 2024 / Theralase Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the ...